Stockpicker Comparison Tool
Nothing here is comparable yet for these companies.
Revenue Growth
CURI
22.26%
▲ 21.79%
UPXI
44.19%
▼ -56.83%
Gross Margin
CURI
72.84%
▲ 16.75%
UPXI
93.11%
▲ 11.67%
Free Cash Flow
CURI
-$4.16M
▼ -$5.37M
UPXI
-$4.79M
▼ -$9.75M
Net Debt / EBITDA
CURI
-0.18
▲ 1.76
UPXI
-0.57
▲ 1.26
Operating Margin
CURI
39.49%
▲ 49.68%
UPXI
-127.67%
▼ -14.58%
P/E Ratio
CURI
9840.34
UPXI
3.42
▼ -29.49